Zevra Therapeutics ZVRA
NASDAQ ZVRA
$10.36 -0.11 (-1.05%)
At close: Oct 21, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Raw Materials (2023 - 2024)

Updated

Zevra Therapeutics' Raw Materials was $4.55 million in Q3 2024, down 5.7% from the prior quarter.

Analysis

Zevra Therapeutics (ZVRA) Raw Materials (2023 - 2024) Analysis & Trends

At the end of FY2023, Raw Materials at Zevra Therapeutics came in at $2.94 million.

  • Quarterly Raw Materials has moved between $2.94 million (Q4 2023) and $4.82 million (Q2 2024) over five years.
  • Per Business Quant data, ZVRA's Raw Materials in the three quarters before Q3 2024 was $4.82 million (Q2 2024), $4.04 million (Q1 2024) and $2.94 million (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Zevra Therapeutics 612.56 Mn -200.15 Mn 38.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 4.55 Mn
Jun 30, 2024 4.82 Mn
Mar 31, 2024 4.04 Mn
Dec 31, 2023 2.94 Mn
API Access

Zevra Therapeutics Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=ZVRA&period=max&api_key=YOUR_API_KEY